Insertional oncogenesis in gene therapy: how much of a risk?
- 18 March 2004
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 11 (7) , 569-573
- https://doi.org/10.1038/sj.gt.3302243
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Gene Therapy Insertional Mutagenesis InsightsScience, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Second Child in French Trial Is Found to Have LeukemiaScience, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- High-throughput retroviral tagging to identify components of specific signaling pathways in cancerNature Genetics, 2002
- New genes involved in cancer identified by retroviral taggingNature Genetics, 2002
- Cytokines and immunodeficiency diseasesNature Reviews Immunology, 2001
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15Nature, 1984
- THE FUTURE FOR GENE THERAPY‐A REEVALUATIONAnnals of the New York Academy of Sciences, 1976